Abstract:Hepatitis C virus (HCV) infection is a major public health burden in China, affecting more than 10 million individuals. We aimed to evaluate the effectiveness of a hospital‐based intervention programme for HCV Surveillance with linkage to care (HEAL) in a prospective cohort. The HEAL programme was carried out targeting inpatients from non‐infectious departments of two tertiary hospitals in Jiangsu, China. It consisted of an educational campaign to raise awareness of physicians from non‐IDs to promote HCV surveillance, a patient‐navigator‐centred clinical algorithm responsible for the efficient follow‐up of patients with positive HCV antibody, including comprehensive testing, diagnosis and treatment. We characterised the rate of linkage to HCV diagnosis, care and treatment during the pre‐intervention period (from 1 July 2016 and June 30, 2018) and after the intervention (from March 2019 to May 2021). During the pre‐intervention period, 89,303 (45.3%) out of 196,780 non‐ID inpatients were screened for anti‐HCV, and 631 patients were tested positive. One hundred and fifty‐six (24.7%) patients was followed up for HCV RNA confirmatory testing, and 58 (37.1%) of patients further were diagnosed with chronic HCV infection (CHC). Only 18 (31.3%) of the diagnosed patients with CHC were linked to hepatitis C clinics for treatment, 10 (55.6%) patients received antiviral regimen. Among them, two (11.1%) received DAA treatment, while eight (44.4%) adopted peginterferon/ribavirin regimen. During the intervention period, 232,275 patients were hospitalised in non‐infectious department and 151,203 (65.1%) were screened for anti‐HCV. Of these, 960 patients tested positive for HCV antibodies, resulting in a prevalence of anti‐HCV positivity of 0.63%. Six hundred and seventy (69.8%) patients were enrolled, and 100% were followed up for HCV RNA confirmatory testing. Two hundred and ninety‐one (43.4%) individuals with active HCV were identified. Two hundred and thirty‐eight (81.8%) of HCV‐infected individuals were linked to HCV care, and 157 (65.9%) were linked to treatment. Compared to the pre‐intervention period, there was a 2.61‐fold increase in the percentage of patients linked to care and a 5.94‐fold increase in the proportion of patients who started DAAs therapy. This HEAL programme achieved enhanced HCV Surveillance with linkage to care, which has been demonstrated as an effective strategy in the hospital setting to improve the hepatitis C care continuum by identifying inpatients unaware of their HCV status and facilitating their access to HCV treatment.

A People-centered Decentralized Outreach Model Toward HCV Micro-elimination in hyperendemic areas: COMPACT Study in SARS Co-V2 pandemic

Significant amelioration of hepatitis C virus infection in a hyperendemic area: longitudinal evidence from the COMPACT Study in Taiwan

Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan

Community-based screening by Anti-HCV reflex HCV Ag test and accessible post-screening care toward elimination of hepatitis C in two hyperendemic townships

Establishment and Development of National Community-Based Collaborative Innovation Demonstration Areas to Achieve the Control Target of Hepatitis B in China

Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C)

Chronic viral hepatitis C micro‐elimination program using telemedicine in Guigang city

Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action

Village-to-village screening for hepatitis B and C using quantitative HBsAg and anti-HCV testing with reflex HCV core antigen tests in the remote communities of a resource-rich setting: a population-based prospective cohort study

Experience Of Offering Hiv Rapid Testing To At-Risk Patients In Community Health Centers In Eight Chinese Cities

Dual strategy involving hospital-based study and community-based screening to eliminate hepatitis C in remote areas

Multi-disciplinary cooperation for the micro-elimination of hepatitis C in China: a hospital-based experience

Scaling up the in-hospital hepatitis C virus care cascade in Taiwan

Challenges of transferring rural adults with chronic HCV infection for further HCV RNA confirmation and free DAAs treatment: a success story of the interdisciplinary collaboration approach

How would China achieve WHO's target of eliminating HCV by 2030?

Hepatitis C virus micro‐elimination in people who inject drugs: Challenges and chance in Taiwan and worldwide

Community Pop‐Up Clinic: Cascade of Care and HCV Treatment of Vancouver's Inner‐City PWID Populations

A Programme of Hepatitis C Surveillance With Active Linkage to Care (HEAL) for Inpatients in Two Tertiary Hospitals in Jiangsu, China

The Impact of COVID-19 on the Cascade of Care of HCV in the US and China

Hepatitis C Virus Cure with Direct-Acting Antivirals: Clinical, Economic, Societal and Patient Value for China

Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan